The North America generic injectables market is witnessing strong expansion, driven by rising demand for cost-effective therapies, increasing chronic disease burden, and a well-established healthcare infrastructure. The region, led by the United States, holds a dominant share in the global market due to high adoption of generics and favorable regulatory frameworks that encourage competition.
In...